For Dermatology Patient Pathways click here
The National Dermatology Patient Pathways should be used in association with drug recommendations and guidance in this section to inform the management of acne, alopecia, atopic eczema, benign skin lesions, generalised and local pruritus, hand and foot eczema, molluscum contagiosum, nail dystrophy, non-melanoma skin cancers, psoriasis, rosacea, scabies, solar (actinic) keratoses and Bowen’s Disease, suspicious pigmented lesions, urticaria, and viral warts.

Last reviewed: 26/10/2021

Next review date: 31/10/2024

Version: 1

Reviewer name(s): Patricia Hannam.

Document Id: TAM480